IRCT2014040117111N1.
Trial name or title | Comparison of the influence Nigella sativa with mefenamic acid on primary dysmenorrhoea |
Methods | RCT |
Participants | Inclusion criteria: age range between 18 to 30 years, single, female students staying in Iran Mashhad University dormitories, with regular menstrual periods of moderate to severe primary dysmenorrhoea grade based on a visual scale Exclusion criteria: history abdominal or pelvic surgery, history of sexual problems or mishaps during study, coagulation disorders or abnormal uterine pelvic ultrasound, consumption of hormonal drugs (e.g. contraception), NSAIDs, opioids, or any sensitivity to drugs, obesity (BMI > 30) Location: Iran |
Interventions | Group 1: oral Nigella sativa 3 g daily (two capsules of 500 mg every 8 hours) during the first 3 days of menstruation Group 2: mefenamic acid 250 mg (two 500 mg capsules with 125 mg of active ingredient mefenamic acid every 8 hours during the first 3 days of menstruation |
Outcomes |
|
Starting date | 01 November 2014 |
Contact information | Farzaneh Jafaarnejad (jaafarnejadf@mums.ac.ir) |
Notes |